Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trude R Balstad

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Nutrients|October 27, 2020
Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-AnalysisAsta Bye, Jon A Sandmael, Guro B Stene, et al.
Laryngoscope Investigative Otolaryngology|April 28, 2020
Physical rehabilitation in patients with head and neck cancer: Impact on health-related quality of life and suitability of a post-treatment programJon Arne Sandmæl, Asta Bye, Tora S Solheim, et al.
Journal of Agricultural and Food Chemistry|October 8, 2009
Activation and inhibition of nuclear factor kappa B activity by cereal extracts: role of dietary phenolic acidsAnastasia S Hole, Stine Grimmer, Kristine Naterstad, et al.
Journal of Circulating Biomarkers|July 29, 2025
A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: a prospective observational studyOla Magne Vagnildhaug, Ragnhild H Habberstad, Øyvind Salvesen, et al.
The Journal of Nutrition|March 22, 2006
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol effluxInger O Ottestad, Bente Halvorsen, Trude R Balstad, et al.
BMJ Supportive & Palliative Care|February 15, 2018
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trialTora S Solheim, Barry J A Laird, Trude R Balstad, et al.
Frontiers in Nutrition|February 15, 2021
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention TrialTrude R Balstad, Cinzia Brunelli, Caroline H Pettersen, et al.
Journal of Pain and Symptom Management|November 5, 2016
Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With CachexiaSally J Wheelwright, Jane B Hopkinson, Anne-Sophie Darlington, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical LandscapeMarianne Erichsen, Tora S Solheim, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nutrients|October 27, 2020
Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-AnalysisAsta Bye, Jon A Sandmael, Guro B Stene, et al.
Laryngoscope Investigative Otolaryngology|April 28, 2020
Physical rehabilitation in patients with head and neck cancer: Impact on health-related quality of life and suitability of a post-treatment programJon Arne Sandmæl, Asta Bye, Tora S Solheim, et al.
Journal of Agricultural and Food Chemistry|October 8, 2009
Activation and inhibition of nuclear factor kappa B activity by cereal extracts: role of dietary phenolic acidsAnastasia S Hole, Stine Grimmer, Kristine Naterstad, et al.
Journal of Circulating Biomarkers|July 29, 2025
A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: a prospective observational studyOla Magne Vagnildhaug, Ragnhild H Habberstad, Øyvind Salvesen, et al.
The Journal of Nutrition|March 22, 2006
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol effluxInger O Ottestad, Bente Halvorsen, Trude R Balstad, et al.
BMJ Supportive & Palliative Care|February 15, 2018
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trialTora S Solheim, Barry J A Laird, Trude R Balstad, et al.
Frontiers in Nutrition|February 15, 2021
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention TrialTrude R Balstad, Cinzia Brunelli, Caroline H Pettersen, et al.
Journal of Pain and Symptom Management|November 5, 2016
Development of the EORTC QLQ-CAX24, A Questionnaire for Cancer Patients With CachexiaSally J Wheelwright, Jane B Hopkinson, Anne-Sophie Darlington, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical LandscapeMarianne Erichsen, Tora S Solheim, Inger Ottestad, et al.
Journal of Cachexia, Sarcopenia and Muscle|March 11, 2025
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints SeriesOlav Dajani, Iain Philips, Ester Kristine Størkson, et al.
Pageof 3